Influence of genetic variations in the SOD1 gene on the development of ascites and spontaneous bacterial peritonitis in decompensated liver cirrhosis

Background The balance between generation and elimination of reactive oxygen species by superoxide dismutase (SOD) is crucially involved in the pathophysiology of liver cirrhosis. Reactive oxygen species damage cells and induce inflammation/fibrosis, but also play a critical role in immune defense from pathogens. As both processes are involved in the development of liver cirrhosis and its complications, genetic variation of the SOD1 gene was investigated. Patients and methods Two SOD1 single nucleotide polymorphisms (rs1041740 and rs3844942) were analyzed in 49 cirrhotic patients undergoing liver transplantation. In addition, 344 cirrhotic patients with ascites were analyzed in a cohort of 521 individuals in terms of the relationship of these polymorphisms with spontaneous bacterial peritonitis (SBP). Results Although rs3844942 showed no associations with complications of cirrhosis, we observed a significant association between rs1041740 and the presence of ascites and SBP in the discovery cohort of patients with cirrhosis. Importantly, the association with SBP was not confirmed in the validation cohort of patients with ascites. By contrast, a trend toward lower SBP rates was observed in carriers of rs1041740. In this cohort, rs1041740 was not associated with survival. Conclusion These data suggest a complex role of SOD1 in different processes leading to complications of liver cirrhosis. rs1041740 might be associated with the development of ascites and possibly plays a role in SBP once ascites has developed.

[1]  E. Duell Telomere length and pancreatic cancer risk: breaking down the evidence , 2016, Gut.

[2]  R. Kawasaki,et al.  The Impact of Superoxide Dismutase-1 Genetic Variation on Cardiovascular and All-Cause Mortality in a Prospective Cohort Study: The Yamagata (Takahata) Study , 2016, PloS one.

[3]  D. Kienhöfer,et al.  Reactive oxygen homeostasis – the balance for preventing autoimmunity , 2016, Lupus.

[4]  P. Ginès,et al.  Management of uninfected and infected ascites in cirrhosis , 2016, Liver international : official journal of the International Association for the Study of the Liver.

[5]  C. Strassburg,et al.  A variant in the nuclear dot protein 52kDa gene increases the risk for spontaneous bacterial peritonitis in patients with alcoholic liver cirrhosis. , 2016, Digestive and liver disease : official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver.

[6]  C. Strassburg,et al.  Janus-kinase-2 relates directly to portal hypertension and to complications in rodent and human cirrhosis , 2015, Gut.

[7]  E. Nice,et al.  Redox Regulation of Inflammation: Old Elements, a New Story , 2015, Medicinal research reviews.

[8]  J. García‐Pagán,et al.  Functional aspects on the pathophysiology of portal hypertension in cirrhosis. , 2012, Journal of hepatology.

[9]  M. Marre,et al.  Allelic variations in superoxide dismutase-1 (SOD1) gene and renal and cardiovascular morbidity and mortality in type 2 diabetic subjects. , 2012, Molecular genetics and metabolism.

[10]  S. Hadjadj,et al.  Allelic variations in superoxide dismutase-1 (SOD1) gene are associated with increased risk of diabetic nephropathy in type 1 diabetic subjects. , 2011, Molecular genetics and metabolism.

[11]  Dae-Yeul Yu,et al.  Oxidative stress and antioxidants in hepatic pathogenesis. , 2010, World journal of gastroenterology.

[12]  P. Muriel Role of free radicals in liver diseases , 2009, Hepatology international.

[13]  D. Heistad,et al.  Superoxide dismutase gene transfer reduces portal pressure in CCl4 cirrhotic rats with portal hypertension , 2008, Gut.

[14]  W. Dröge,et al.  Oxidative stress and aberrant signaling in aging and cognitive decline , 2007, Aging cell.

[15]  J. Bosch,et al.  Potential role of antioxidants in the treatment of portal hypertension. , 2007, Journal of hepatology.

[16]  D. Leibfritz,et al.  Free radicals and antioxidants in normal physiological functions and human disease. , 2007, The international journal of biochemistry & cell biology.

[17]  Jian Wu,et al.  Molecular therapy for hepatic injury and fibrosis: where are we? , 2006, World journal of gastroenterology.